"It is incredible that my daughter has kept her sight, in our country they told me that it was impossible"
"The oncology team managed to get our son's neuroblastoma into remission: we are truly grateful" Maryan, diagnosed with grade-4 neuroblastoma when he was 18 months old, received chemotherapy, surgery, radiation therapy and immunotherapy at SJD...
The Oncology Unit at SJD Barcelona Children's Hospital stabilises a high-grade glioma thanks to targeted therapies The joint work of the healthcare and research team, together with a precise diagnosis from the molecular biology laboratory and the surgical team'...
IRSJD researchers collaborate in the identification of two subtypes of retinoblastoma The study in which the Institut de Recerca Sant Joan de Déu is collaborating will help to improve the diagnosis and treatment of this childhood ca...
The Orthopedics and Traumatology Department performs the first scoliosis surgery with augmented reality in Spain In a young woman from Bilbao, this technology helped place the screws with greater precision to correct the severe curve in her spine.
Measuring antibodies in saliva is a useful and easy strategy to detect SARS-CoV-2 infections The study results from a collaboration between SJD Barcelona Children’s Hospital and ISGlobal, and tested over 1,500 children in Barcelona during ...
The Hospitality programme has helped more than 70 families facing lodging difficulties during lockdown The programme also advises and helps families with accommodation so that they can rest comfortably while their child is admitted to SJD Barcelona ...
"It is important to stop retinoblastoma from progressing to prevent risk to the patient's life" This is the first patient to be officially treated by the Pediatric Cancer Center Barcelona, a case of retinoblastoma treated with intra-arterial ...
The Kids Corona study reveals a low infection rate in summer camps The distribution of children into bubble groups has been shown to be effective in containing the transmission of the infection and in avoiding the...
SJD researchers publish the results of the latest generation immunotherapy treatment for neuroblastoma These results demonstrate that treatment with the humanized anti-GD2 antibody Naxitamab is a possible pathway for treat and therefore should conti...
